FDA 483 - Maiva Pharma Private Limited - October 29, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Maiva Pharma Private Limited, a sterile drug manufacturer in Hosur, India, revealed significant deficiencies across its operations. The firm was cited for severe issues with data integrity and computer system controls, inadequate environmental monitoring in aseptic processing areas, and insufficient validation of cleaning, disinfection, and aseptic processes. Additionally, the firm failed to properly document personnel performing critical manufacturing steps and exhibited poor airflow control and visualization studies.
ID · d92be8a0-4356-4d0e-b6ee-a42c44642842